{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T20:51:32Z","timestamp":1782420692838,"version":"3.54.5"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T00:00:00Z","timestamp":1746230400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T00:00:00Z","timestamp":1746230400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"This study received a financial research support for teaching assistants from Faculty of Pharmacy, Cairo University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-025-04505-2","type":"journal-article","created":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T12:59:15Z","timestamp":1746277155000},"page":"3611-3624","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The nephroprotective effect of metformin with cisplatin in bladder cancer: randomized clinical trial"],"prefix":"10.1007","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-2289-9289","authenticated-orcid":false,"given":"Samah E.","family":"Mahran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salem Eid","family":"Salem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirmeen A.","family":"Sabry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6048-847X","authenticated-orcid":false,"given":"Samar F.","family":"Farid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,3]]},"reference":[{"key":"4505_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2019.102925","volume":"88","author":"S Ghosh","year":"2019","unstructured":"Ghosh S (2019) Cisplatin: The first metal based anticancer drug. Bioorg Chem 88:102925","journal-title":"Bioorg Chem"},{"issue":"1","key":"4505_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.13005\/bpj\/1608","volume":"12","author":"SA Aldossary","year":"2019","unstructured":"Aldossary SA (2019) Review on pharmacology of cisplatin: clinical use, toxicity and mechanism of resistance of cisplatin. Biomed Pharmacol J 12(1):7\u201315","journal-title":"Biomed Pharmacol J"},{"issue":"3","key":"4505_CR3","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1097\/SPC.0000000000000505","volume":"14","author":"A Desilets","year":"2020","unstructured":"Desilets A, Adam J-P, Souli\u00e8res D (2020) Management of cisplatin-associated toxicities in bladder cancer patients. Curr Opin Support Palliat Care 14(3):286\u2013292","journal-title":"Curr Opin Support Palliat Care"},{"key":"4505_CR4","first-page":"S49","volume":"17","author":"S Hemati","year":"2012","unstructured":"Hemati S, Arbab Jolfaie N, Gookizadeh A, Rafienia M, Ghavamnasiri M (2012) The effects of vitamin E and selenium on cisplatin-induced nephrotoxicity in cancer patients treated with cisplatin-based chemotherapy: A randomized, placebo-controlled study. J Res Med Sci 17:S49-58","journal-title":"J Res Med Sci"},{"issue":"1","key":"4505_CR5","first-page":"4","volume":"3","author":"SS Ha","year":"2021","unstructured":"Ha SS, Rubaina K, Lee C-S, John V, Seetharamu N (2021) Amifostine is a nephro-protectant in patients receiving treatment with cisplatin-myth, mystery or matter-of-fact? J Nephrol Dialysis Med 3(1):4\u20138","journal-title":"J Nephrol Dialysis Med"},{"issue":"10061","key":"4505_CR6","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1016\/S0140-6736(16)30512-8","volume":"388","author":"AM Kamat","year":"2016","unstructured":"Kamat AM et al (2016) Bladder cancer. The Lancet 388(10061):2796\u20132810","journal-title":"The Lancet"},{"issue":"5","key":"4505_CR7","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.eprac.2023.02.001","volume":"29","author":"SL Samson","year":"2023","unstructured":"Samson SL et al (2023) American Association of Clinical Endocrinology Consensus Statement: comprehensive type 2 diabetes management algorithm\u20132023 update. Endocr Pract 29(5):305\u2013340","journal-title":"Endocr Pract"},{"key":"4505_CR8","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3389\/fendo.2020.00191","volume":"11","author":"Z Lv","year":"2020","unstructured":"Lv Z, Guo Y (2020) Metformin and its benefits for various diseases. Front Endocrinol (Lausanne) 11:191","journal-title":"Front Endocrinol (Lausanne)"},{"key":"4505_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111454","volume":"138","author":"A Song","year":"2021","unstructured":"Song A, Zhang C, Meng X (2021) Mechanism and application of metformin in kidney diseases: An update. Biomed Pharmacother 138:111454","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"4505_CR10","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1159\/000481951","volume":"138","author":"ME De Broe","year":"2018","unstructured":"De Broe ME, Kajbaf F, Lalau J-D (2018) Renoprotective effects of metformin. Nephron 138(4):261\u2013274","journal-title":"Nephron"},{"issue":"20","key":"4505_CR11","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","volume":"310","author":"WM Association","year":"2013","unstructured":"Association WM (2013) World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 310(20):2191\u20132194","journal-title":"JAMA"},{"issue":"5","key":"4505_CR12","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1093\/ndt\/gfn009","volume":"23","author":"SM Bagshaw","year":"2008","unstructured":"Bagshaw SM, George C, Bellomo R (2008) A comparison of the RIFLE and AKIN criteria for acute kidney injury in critically ill patients. Nephrol Dial Transplant 23(5):1569\u20131574","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"4505_CR13","first-page":"16","volume":"2","author":"N Lawson","year":"1993","unstructured":"Lawson N, Jodrell D, McMURRAY A (1993) Cisplatin and carboplatin: a guide to administration. Eur J Cancer Care (Engl) 2(1):16\u201320","journal-title":"Eur J Cancer Care (Engl)"},{"issue":"2","key":"4505_CR14","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.clnu.2012.08.006","volume":"32","author":"A Esteghamati","year":"2013","unstructured":"Esteghamati A et al (2013) Effects of metformin on markers of oxidative stress and antioxidant reserve in patients with newly diagnosed type 2 diabetes: a randomized clinical trial. Clin Nutr 32(2):179\u2013185","journal-title":"Clin Nutr"},{"issue":"12","key":"4505_CR15","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1055\/s-0032-1321878","volume":"44","author":"Y Ishibashi","year":"2012","unstructured":"Ishibashi Y, Matsui T, Takeuchi M, Yamagishi S (2012) Metformin inhibits advanced glycation end products (AGEs)-induced renal tubular cell injury by suppressing reactive oxygen species generation via reducing receptor for AGEs (RAGE) expression. Horm Metab Res 44(12):891\u2013895","journal-title":"Horm Metab Res"},{"issue":"2","key":"4505_CR16","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/j.1872-034X.2007.00215.x","volume":"38","author":"CPMS De Oliveira","year":"2008","unstructured":"De Oliveira CPMS et al (2008) Combination of N-acetylcysteine and metformin improves histological steatosis and fibrosis in patients with non-alcoholic steatohepatitis. Hepatol Res 38(2):159\u2013165","journal-title":"Hepatol Res"},{"issue":"sup241","key":"4505_CR17","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1080\/00365510802150158","volume":"68","author":"P Devarajan","year":"2008","unstructured":"Devarajan P (2008) Neutrophil gelatinase-associated lipocalin (NGAL): a new marker of kidney disease. Scand J Clin Lab Invest 68(sup241):89\u201394","journal-title":"Scand J Clin Lab Invest"},{"issue":"2","key":"4505_CR18","doi-asserted-by":"publisher","first-page":"307","DOI":"10.33549\/physiolres.934212","volume":"69","author":"B Florova","year":"2020","unstructured":"Florova B, Rajdl D, Racek J, Fiala O, Matejka VM, Trefil L (2020) NGAL, albumin and cystatin C during cisplatin therapy. Physiol Res 69(2):307","journal-title":"Physiol Res"},{"issue":"9","key":"4505_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12032-021-01558-y","volume":"38","author":"E Ghonaim","year":"2021","unstructured":"Ghonaim E, El-Haggar S, Gohar S (2021) Possible protective effect of pantoprazole against cisplatin-induced nephrotoxicity in head and neck cancer patients: a randomized controlled trial. Med Oncol 38(9):1\u201312","journal-title":"Med Oncol"},{"issue":"5","key":"4505_CR20","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1007\/s11255-022-03418-8","volume":"55","author":"S Volovat","year":"2023","unstructured":"Volovat S et al (2023) Cisplatin and AKI: an ongoing battle with new perspectives\u2014a narrative review. Int Urol Nephrol 55(5):1205\u20131209","journal-title":"Int Urol Nephrol"},{"issue":"1","key":"4505_CR21","doi-asserted-by":"publisher","first-page":"23975","DOI":"10.1038\/srep23975","volume":"6","author":"J Li","year":"2016","unstructured":"Li J et al (2016) Metformin protects against cisplatin-induced tubular cell apoptosis and acute kidney injury via AMPK\u03b1-regulated autophagy induction. Sci Rep 6(1):23975","journal-title":"Sci Rep"},{"issue":"2","key":"4505_CR22","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41585-020-00404-6","volume":"18","author":"DM Jiang","year":"2021","unstructured":"Jiang DM et al (2021) Defining cisplatin eligibility in patients with muscle-invasive bladder cancer. Nat Rev Urol 18(2):104\u2013114","journal-title":"Nat Rev Urol"},{"issue":"3","key":"4505_CR23","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.annonc.2021.11.012","volume":"33","author":"T Powles","year":"2022","unstructured":"Powles T et al (2022) Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up\u2606. Ann Oncol 33(3):244\u2013258","journal-title":"Ann Oncol"},{"issue":"11","key":"4505_CR24","doi-asserted-by":"publisher","first-page":"3441","DOI":"10.3390\/molecules26113441","volume":"26","author":"VU Nna","year":"2021","unstructured":"Nna VU, Abu Bakar AB, Zakaria Z, Othman ZA, Jalil NAC, Mohamed M (2021) Malaysian propolis and metformin synergistically mitigate kidney oxidative stress and inflammation in streptozotocin-induced diabetic rats. Molecules 26(11):3441","journal-title":"Molecules"},{"issue":"11","key":"4505_CR25","first-page":"1355","volume":"45","author":"J Quan","year":"2020","unstructured":"Quan J, Jiang Y, Lu R, Chen Y, Tao L, Peng Z (2020) Therapeutic effect of metformin on rats with cisplatin-induced acute kidney injury. Zhong Nan Da Xue Xue Bao Yi Xue Ban 45(11):1355\u20131360","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"key":"4505_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113377","volume":"153","author":"G Harley","year":"2022","unstructured":"Harley G et al (2022) Blocking AMPK signalling to acetyl-CoA carboxylase increases cisplatin-induced acute kidney injury and suppresses the benefit of metformin. Biomed Pharmacother 153:113377","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"4505_CR27","doi-asserted-by":"publisher","first-page":"45","DOI":"10.21608\/amj.2020.67536","volume":"49","author":"M Assasa","year":"2020","unstructured":"Assasa M, El-Raheem A, Said AE-L, Hassan AI (2020) Evaluation of the possible protective effect of metformin in cisplatin-induced nephrotoxicity in adult male albino rats. Al-Azhar Med J 49(1):45\u201358","journal-title":"Al-Azhar Med J"},{"key":"4505_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2024.114301","volume":"210","author":"L Steventon","year":"2024","unstructured":"Steventon L et al (2024) The impact of inter-cycle treatment delays on 5-year all-cause mortality in early-stage breast cancer: a retrospective cohort study. Eur J Cancer 210:114301","journal-title":"Eur J Cancer"},{"issue":"1","key":"4505_CR29","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.eururo.2020.03.055","volume":"79","author":"JA Witjes","year":"2021","unstructured":"Witjes JA et al (2021) European Association of Urology guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2020 guidelines. Eur Urol 79(1):82\u2013104","journal-title":"Eur Urol"},{"issue":"1","key":"4505_CR30","first-page":"1462802","volume":"2018","author":"M Per\u0161e","year":"2018","unstructured":"Per\u0161e M, Ve\u010deri\u0107-Haler \u017d (2018) Cisplatin-induced rodent model of kidney injury: characteristics and challenges. Biomed Res Int 2018(1):1462802","journal-title":"Biomed Res Int"},{"issue":"9","key":"4505_CR31","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1007\/s00125-017-4343-y","volume":"60","author":"SM Marshall","year":"2017","unstructured":"Marshall SM (2017) 60 years of metformin use: a glance at the past and a look to the future. Diabetologia 60(9):1561\u20131565","journal-title":"Diabetologia"},{"issue":"1","key":"4505_CR32","volume":"2015","author":"P Ranganath","year":"2015","unstructured":"Ranganath P, Einhorn L, Albany C (2015) Management of chemotherapy induced nausea and vomiting in patients on multiday cisplatin based combination chemotherapy. Biomed Res Int 2015(1):943618","journal-title":"Biomed Res Int"},{"issue":"2","key":"4505_CR33","first-page":"379","volume":"10","author":"F Fahimi","year":"2011","unstructured":"Fahimi F, Khodadad K, Amini S, Naghibi F, Salamzadeh J, Baniasadi S (2011) Evaluating the effect of Zingiber officinalis on nausea and vomiting in patients receiving cisplatin based regimens. Iran J Pharm Res 10(2):379","journal-title":"Iran J Pharm Res"},{"issue":"10","key":"4505_CR34","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1200\/JCO.1985.3.10.1379","volume":"3","author":"MG Kris","year":"1985","unstructured":"Kris MG et al (1985) Incidence, course, and severity of delayed nausea and vomiting following the administration of high-dose cisplatin. J Clin Oncol 3(10):1379\u20131384","journal-title":"J Clin Oncol"},{"issue":"11","key":"4505_CR35","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1002\/1097-0142(19850601)55:11<2645::AID-CNCR2820551119>3.0.CO;2-J","volume":"55","author":"H Krebs","year":"1985","unstructured":"Krebs H, Myers MB, Wheelock JB, Goplerud DR (1985) Combination antiemetic therapy in cisplatin-induced nausea and vomiting. Cancer 55(11):2645\u20132648","journal-title":"Cancer"},{"issue":"10","key":"4505_CR36","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/s41574-019-0242-2","volume":"15","author":"M Foretz","year":"2019","unstructured":"Foretz M, Guigas B, Viollet B (2019) Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus. Nat Rev Endocrinol 15(10):569\u2013589","journal-title":"Nat Rev Endocrinol"},{"issue":"8","key":"4505_CR37","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.4103\/jfmpc.jfmpc_490_19","volume":"8","author":"N Sharma","year":"2019","unstructured":"Sharma N, Lugani Y, Kaur A, Ahuja VK (2019) Effect of metformin on insulin levels, blood sugar, and body mass index in polycystic ovarian syndrome cases. J Family Med Prim Care 8(8):2691\u20132695","journal-title":"J Family Med Prim Care"},{"issue":"6","key":"4505_CR38","doi-asserted-by":"publisher","first-page":"e14104","DOI":"10.1111\/ijcp.14104","volume":"75","author":"MS Abdel Monem","year":"2021","unstructured":"Abdel Monem MS et al (2021) The potential hepatoprotective effect of metformin in hepatitis C virus-infected adolescent patients with beta thalassemia major: Randomised clinical trial. Int J Clin Pract 75(6):e14104","journal-title":"Int J Clin Pract"},{"issue":"1","key":"4505_CR39","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1089\/met.2023.0164","volume":"22","author":"AM Kamel","year":"2024","unstructured":"Kamel AM, Ismail B, Abdel Hafiz G, Sabry N, Farid S (2024) Effect of Metformin on Oxidative Stress and Left Ventricular Geometry in Nondiabetic Heart Failure Patients: A Randomized Controlled Trial. Metab Syndr Relat Disord 22(1):49\u201358","journal-title":"Metab Syndr Relat Disord"},{"issue":"2","key":"4505_CR40","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/S2213-8587(13)70152-9","volume":"2","author":"D Preiss","year":"2014","unstructured":"Preiss D et al (2014) Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial. Lancet Diabetes Endocrinol 2(2):116\u2013124","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"9","key":"4505_CR41","doi-asserted-by":"publisher","first-page":"3118","DOI":"10.1210\/en.2013-1179","volume":"154","author":"JM Garcia","year":"2013","unstructured":"Garcia JM et al (2013) Inhibition of cisplatin-induced lipid catabolism and weight loss by ghrelin in male mice. Endocrinology 154(9):3118\u20133129","journal-title":"Endocrinology"},{"issue":"2","key":"4505_CR42","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1254\/jjp.40.353","volume":"40","author":"K Sugihara","year":"1986","unstructured":"Sugihara K, Gemba M (1986) Modification of cisplatin toxicity by antioxidants. The Japanese J Pharmacol 40(2):353\u2013355","journal-title":"The Japanese J Pharmacol"},{"issue":"3","key":"4505_CR43","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1177\/1534735417753543","volume":"17","author":"M-T Lin","year":"2018","unstructured":"Lin M-T, Ko J-L, Liu T-C, Chao P-T, Ou C-C (2018) Protective effect of D-methionine on body weight loss, anorexia, and nephrotoxicity in cisplatin-induced chronic toxicity in rats. Integr Cancer Ther 17(3):813\u2013824","journal-title":"Integr Cancer Ther"},{"issue":"4","key":"4505_CR44","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.3892\/or.2013.2279","volume":"29","author":"L Astolfi","year":"2013","unstructured":"Astolfi L et al (2013) Correlation of adverse effects of cisplatin administration in patients affected by solid tumours: A retrospective evaluation. Oncol Rep 29(4):1285\u20131292","journal-title":"Oncol Rep"},{"key":"4505_CR45","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s40261-017-0564-6","volume":"37","author":"W Huang","year":"2017","unstructured":"Huang W, Castelino RL, Peterson GM (2017) Lactate levels with chronic metformin use: a narrative review. Clin Drug Investig 37:991\u20131007","journal-title":"Clin Drug Investig"},{"issue":"4","key":"4505_CR46","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1002\/jcp.25598","volume":"232","author":"S Ravindran","year":"2017","unstructured":"Ravindran S, Kuruvilla V, Wilbur K, Munusamy S (2017) Nephroprotective effects of metformin in diabetic nephropathy. J Cell Physiol 232(4):731\u2013742","journal-title":"J Cell Physiol"},{"issue":"11","key":"4505_CR47","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1111\/j.1742-1241.2007.01487.x","volume":"61","author":"VCC Lim","year":"2007","unstructured":"Lim VCC, Sum CF, Chan ESY, Yeoh LY, Lee YM, Lim SC (2007) Lactate levels in Asian patients with type 2 diabetes mellitus on metformin and its association with dose of metformin and renal function. Int J Clin Pract 61(11):1829\u20131833","journal-title":"Int J Clin Pract"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-025-04505-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-025-04505-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-025-04505-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T14:22:32Z","timestamp":1759846952000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-025-04505-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,3]]},"references-count":47,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["4505"],"URL":"https:\/\/doi.org\/10.1007\/s11255-025-04505-2","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,3]]},"assertion":[{"value":"3 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Research and Ethics Committee for Experimental and Clinical Studies, Faculty of Pharmacy, Cairo University. All procedures performed in the study involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All participants provided written informed consent before participation in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}